Are there trial results available for CB or what is up with it?
Breezula (aka "CB-13-01," aka "cortexolone-17α-propionate" 5% topical lotion) is on track for an expected launch in 2021. Hold fast! The product is currently entering Phase II Dose Range trials in 2017. You can track the progress at the manufacturer, Cassiopea's, website:
cassiopea.com/activities/product-pipeline.aspx
Cheers!
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm521263.htm
if only this could be the case for us.
Breezula™ acts at cutaneous level on the scalp by blocking DHT interaction with the specific hair-follicle androgen receptors. Breezula™ also reduces the skin’s production of prostaglandin D2, a hormone-like compound that, in elevated levels, can inhibit hair growth.
Was this known?
I don't think I've ever read them saying that it also reduced PGD2.